Skip to content
PubMed This is a summary of 11 peer-reviewed journal articles Updated
Gastroenterology · Erosive Esophagitis

Will Heartburn Worsen After Stopping a PPI for Esophagitis?

At a Glance

Heartburn can briefly worsen after stopping a PPI because the stomach temporarily makes extra acid, but ongoing or severe symptoms may signal returning reflux or unhealed erosive esophagitis. Ask your gastroenterologist whether tapering or long-term treatment is safest.

Yes, it is possible that your heartburn will come back—and sometimes feel even worse than before—if you stop taking your proton pump inhibitor (PPI). This temporary surge in symptoms is a recognized effect known as rebound acid hypersecretion (often called acid rebound) [1][2]. It can be frightening to experience this flare-up, but it is important to know that rebound is a temporary medication effect, not an addiction. Doctors frequently warn patients about the possibility of rebound symptoms so they do not mistakenly believe a short-term flare-up proves they must stay on the medication for life [1].

When to Seek Urgent Care

Before making any changes to your medication, you should be aware of “alarm symptoms” that require prompt medical evaluation. Chest pain should not automatically be attributed to heartburn, as it can be cardiac. Seek urgent medical help if you experience:

  • Difficulty swallowing, pain with swallowing, or the sensation of food getting stuck in your chest
  • Vomiting blood or noticing black, tarry stools
  • Persistent vomiting or unexplained weight loss
  • Severe or new chest pain, especially with shortness of breath, sweating, or exertion

What is Acid Rebound?

PPIs (a highly potent class of acid blockers) are very effective at reducing the amount of acid your stomach produces. When your stomach acid is consistently low over a period of weeks or months, your body tries to compensate by producing more of a hormone called gastrin, which normally signals your stomach to make acid [1][2].

When you stop taking the PPI, your stomach is no longer blocked from making acid, but those elevated gastrin levels are still present. This can cause your stomach to temporarily overproduce acid, leading to a noticeable surge in heartburn and reflux symptoms [1][2]. Studies using pH monitoring (a test that measures actual acid levels in the esophagus) show that symptoms returning after stopping a PPI can correspond to measurable increases in acid exposure [3].

How to Stop Safely: Tapering vs. Direct Discontinuation

There is no single universally proven schedule for coming off a PPI [1][2]. Depending on your original diagnosis, your dose, and how long you have been taking the medication, your doctor may recommend either stopping directly or using a tapering approach (often called step-down therapy).

If you and your doctor decide on a step-down approach, it usually involves:

  • Gradually lowering the dose: Taking a lower daily dose or taking the medication every other day.
  • Transitioning to milder medications: Switching from a PPI to an H2 blocker (a different, less potent type of acid reducer).
  • Using rescue medications: Managing temporary breakthrough symptoms with over-the-counter antacids or alginate therapy (medications that form a protective foam “raft” over your stomach contents to physically block acid from splashing up) [4].
  • Safety Note: Always check with a pharmacist or your doctor before using over-the-counter rescue medications. They can interact with other drugs, and some formulations require caution if you have kidney disease.

Rebound vs. Underlying Erosive Esophagitis

Rebound symptoms and recurrent reflux can occur at the same time, and it is impossible to distinguish between the two based on symptoms alone [3]. If your symptoms persist or worsen over time, they may not be a temporary rebound effect; you may need medical reassessment [5].

For uncomplicated, non-erosive reflux, a short 4- to 8-week trial of PPI therapy is often sufficient [6][7]. However, the treatment for erosive esophagitis is different. Erosive esophagitis is a condition where stomach acid has caused visible physical damage (erosions) to the lining of your esophagus. Doctors measure this damage using the Los Angeles (LA) grading system:

  • Mild (LA Grades A or B): After the esophagus has completely healed, some patients with mild erosive disease may be candidates to step down their medication or use it only as needed [8].
  • Severe (LA Grades C or D): Patients with severe disease generally require ongoing maintenance therapy (long-term acid suppression) to keep the esophagus healed and prevent severe damage from returning [9][10][11].

A follow-up endoscopy is especially recommended for severe disease to confirm healing and to check for complications [9]. Furthermore, long-term PPI use is also indicated if you have Barrett’s esophagus, a history of peptic strictures or ulcers, prior gastrointestinal bleeding, or if you take NSAIDs that put you at risk for ulcers [10][11].

Never change your medication routine without a personalized plan from your gastroenterologist. While lifestyle measures—like identifying personal food triggers and using evidence-based head-of-bed elevation for nighttime symptoms—can offer valuable individualized support, they should not replace necessary medical treatment.

Common questions in this guide

Why can heartburn worsen after I stop a PPI?
PPIs lower stomach acid, and after weeks or months the body may raise gastrin, a hormone that stimulates acid production. When the PPI is stopped, acid production can temporarily overshoot, causing rebound heartburn; this is a medication effect, not an addiction.
Can I stop my PPI if I have erosive esophagitis?
It depends on the severity of the disease and whether the esophagus has healed. Some people with healed mild disease, classified as LA grades A or B, can step down treatment, while severe disease, classified as grades C or D, generally needs ongoing maintenance treatment.
Should I taper my PPI or stop it all at once?
There is no single schedule that is right for everyone. A gastroenterologist may recommend stopping directly or using a step-down plan based on your diagnosis, dose, treatment duration, and health risks, so do not change your routine without medical guidance.
How can I tell whether my symptoms are acid rebound or esophagitis returning?
Heartburn symptoms alone cannot reliably distinguish temporary acid rebound from returning reflux or unhealed erosive esophagitis. If symptoms persist or worsen, a clinician may reassess you with testing such as endoscopy or pH monitoring.
What symptoms mean I need urgent care after stopping my PPI?
Seek urgent medical help for severe or new chest pain, especially with shortness of breath, sweating, or exertion. Difficulty or pain with swallowing, food sticking, vomiting blood, black stools, persistent vomiting, and unexplained weight loss also require prompt medical evaluation.
Are antacids or alginates safe during a PPI step-down?
Antacids, alginate products, or an H2 blocker may help breakthrough symptoms when recommended by a clinician or pharmacist. Ask before using them because they can interact with other medicines, and some products require caution if you have kidney disease.
Will I need a follow-up endoscopy after erosive esophagitis?
Follow-up endoscopy is especially recommended for severe erosive esophagitis to confirm healing and check for complications. Your gastroenterologist can determine whether it is needed based on your LA grade and other health risks.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What was my specific Los Angeles (LA) grade for my erosive esophagitis (A, B, C, or D), and is a follow-up endoscopy necessary to confirm healing?
  2. 2.Based on my LA grade and overall health, am I a candidate for stepping down my PPI dose, or is long-term maintenance therapy medically necessary for my condition?
  3. 3.Do I have any other conditions—like Barrett's esophagus or a history of ulcers—that make ongoing acid suppression necessary?
  4. 4.If we decide to try a step-down approach, what specific tapering schedule should I follow, and when should I contact you if symptoms persist?
  5. 5.Which over-the-counter rescue medications (like specific alginates or antacids) are safe for me to use given my other medications and kidney health?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (11)
  1. 1

    Rebound Acid Hypersecretion after Withdrawal of Long-Term Proton Pump Inhibitor (PPI) Treatment-Are PPIs Addictive?

    Namikawa K, Björnsson ES

    International journal of molecular sciences 2024; (25(10)) doi:10.3390/ijms25105459.

    PMID: 38791497
  2. 2

    Side Effects of Long-Term Proton Pump Inhibitor Use: A Review.

    Haastrup PF, Thompson W, Søndergaard J, Jarbøl DE

    Basic & clinical pharmacology & toxicology 2018; (123(2)):114-121 doi:10.1111/bcpt.13023.

    PMID: 29658189
  3. 3

    Symptomatic recurrence upon proton pump inhibitor discontinuation correlated with results of Bravo® wireless esophageal pH monitoring in patients with gastroesophageal reflux disease.

    Coss-Adame E

    Revista de gastroenterologia de Mexico 2017; (82(4)):275-276 doi:10.1016/j.rgmx.2017.07.002.

    PMID: 28830621
  4. 4

    Randomised clinical trial: addition of alginate-antacid (Gaviscon Double Action) to proton pump inhibitor therapy in patients with breakthrough symptoms.

    Coyle C, Crawford G, Wilkinson J, et al.

    Alimentary pharmacology & therapeutics 2017; (45(12)):1524-1533 doi:10.1111/apt.14064.

    PMID: 28464343
  5. 5

    Persistent gastro-oesophageal reflux symptoms despite proton pump inhibitor therapy.

    Ang D, How CH, Ang TL

    Singapore medical journal 2016; (57(10)):546-551 doi:10.11622/smedj.2016167.

    PMID: 27779277
  6. 6

    The management of gastro-oesophageal reflux disease.

    Keung C, Hebbard G

    Australian prescriber 2016; (39(1)):6-10 doi:10.18773/austprescr.2016.003.

    PMID: 27041798
  7. 7

    Empirical treatment of outpatients with gastroesophageal reflux disease with proton pump inhibitors: A survey of Chinese patients (the ENLIGHT Study).

    Lu B, Zhang L, Wang J, et al.

    Journal of gastroenterology and hepatology 2018; (33(10)):1722-1727 doi:10.1111/jgh.14143.

    PMID: 29575167
  8. 8

    Efficacy of Step-Down Therapy Using Vonoprazan for Symptomatic Mild Reflux Esophagitis.

    Ochiai Y, Kikuchi D, Hoteya S

    Gastroenterology research and practice 2024; (2024()):5620034 doi:10.1155/grp/5620034.

    PMID: 39624644
  9. 9

    Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2021.

    Iwakiri K, Fujiwara Y, Manabe N, et al.

    Journal of gastroenterology 2022; (57(4)):267-285 doi:10.1007/s00535-022-01861-z.

    PMID: 35226174
  10. 10

    The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice From the American Gastroenterological Association.

    Freedberg DE, Kim LS, Yang YX

    Gastroenterology 2017; (152(4)):706-715 doi:10.1053/j.gastro.2017.01.031.

    PMID: 28257716
  11. 11

    Indian consensus on gastroesophageal reflux disease in adults: A position statement of the Indian Society of Gastroenterology.

    Bhatia SJ, Makharia GK, Abraham P, et al.

    Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology 2019; (38(5)):411-440 doi:10.1007/s12664-019-00979-y.

    PMID: 31802441

This page is for informational purposes only and does not constitute medical advice. Do not change your PPI without a personalized plan from your gastroenterologist.

Get notified when new evidence is published on peptic esophagitis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.